Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EQ compared with OVID: revenue, margins and what each company keeps, and the suppliers and customers both name
EQ
Equillium, Inc.
Change
Mkt cap
Revenue
Revenue
OVID
Ovid Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
EQ
Equillium, Inc.
vs
OVID
Ovid Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
EQ, solid
OVID, dashed
Supply-chain overlap
Revenue flow
EQ: latest quarter is a loss; flow not drawable. OVID: latest quarter is a loss; flow not drawable.
Method
›
EQ
Equillium, Inc.
Change
1.38
▼
−2.90%
· post 1.38
Mkt cap
$86.9M
Revenue
$4M
Q4 FY24
Revenue
$41M
FY24
OVID
Ovid Therapeutics Inc.
Change
2.55
▼
−0.45%
· post 2.54
Closed
Oct 30 '26
Mkt cap
$496.1M
Revenue
$733,000
Q2 FY26
Revenue
$7M
FY25
vs
Compare
Closed
Oct 30 '26
EQ
Equillium, Inc.
vs
OVID
Ovid Therapeutics Inc.
1.38
▼
−2.90%
post 1.38
Price
2.55
▼
−0.45%
post 2.54
$86.9M
Mkt cap
$496.1M
Q4 FY24
$4M
Revenue
$733,000
Q2 FY26
FY24
$41M
Revenue
$7M
FY25
Change
Change
EQ
1.38
▼
−2.90%
vs
OVID
2.55
▼
−0.45%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only EQ
2
—
Biocon
unlisted
supplier
—
Ono Pharmaceutical
unlisted
customer
Shared
0
No shared counterparties.
Only OVID
7
LGND
Ligand Pharmaceuticals
customer
TAK
Takeda
customer
—
Northwestern University
unlisted
supplier
—
AstraZeneca
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier
3 more · OVID chain
›